BioRegenerative Sciences, Inc. Releases I-Ease PF, a Stem Cell-Based, Preservative-Free, Eye Drop for Dry Eye

San Diego, CA, July 20, 2011 --(PR.com)-- Dr. Greg Maguire and Peter Friedman, founders of BioRegenerative Sciences, Inc., a privately owned stem cell therapeutics corporation headquartered in San Diego, CA, USA, announced today the release of I-Ease PF, a topically applied, preservative free, eye drop for relieving the pain and irritation associated with dry eye. BioRegenerative Sciences' clinical studies of I-Ease PF demonstrated that the pain and irritation associated with dry eye was reduced or eliminated in a matter of days following the topical application of I-Ease PF. According to Dr. Greg Maguire, CEO and Chief Scientific Officer of BRS, "BRS' I-Ease PF restores the biochemical properties of the tear film and corneal surface to a healthy state so that the eye tissue is no longer inflamed and irritated." Peter Friedman, President of BRS, said that "I-Ease PF is an easily applied topical eye drop that replaces in the corneal surface what was normally present in the youthful, healthy eye." Dr. Maguire also added, "I-Ease PF uses BRS's patented core technology, known as S2RM TechnologyTM where stem cell released molecules from multiple stem cell types are used to formulate the drops." Maguire and Friedman further stated that molecules comprising the S2RM TechnologyTM replace the multitude of molecules that have been lost in the dry eye condition. Dr. Sidney Clevinger, Medical Director at BRS, stated that "I-Ease PF is an alternative to I-Ease for those that are sensitive to preservatives, or for those that wish to use a preservative-free eye drop." Development of I-Ease PF follows the successful launch of I-Ease in March 2011. BRS's I-Ease PF can be purchased online at: www.bioregenerativesciences.com. For more information, please email sales@bioregenerativesciences.com, or call customer service at 877.892.9991.

###